Latest filing published 17 May 2011 for CARDIOGENESIS CORP /CA.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Paul Mccormick: trading record in brief
Paul Mccormick discloses dealings in 2 companies, chiefly Cardiogenesis Corp /CA and Endologix Inc /DE/. We count 40 filings; the first trade dates from 25 May 2007 and the latest from 17 May 2011.
Both buying and selling appear: 22 purchases worth €111k, against 7 sales worth €567k. Taken together, the sales exceed the purchases by €456k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 10 share grants.
The median purchase comes to €2,757.
On 17 May 2011 came the latest disclosure, a transaction in Cardiogenesis Corp /CA. The latest purchase dates back some time: it was published 6,107 days ago, on 18 February 2010. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Paul Mccormick
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 978,926 sharesCommon StockSEC:0001209191-11-028841:0
- 100,000 shares0Common StockSEC:0001209191-10-029000:0
- 200 shares@ US$4.81Common StockSEC:0001209191-10-024890:0
- 19,800 shares@ US$4.81Common StockSEC:0001209191-10-024890:1
- 100 shares@ US$4.80Common StockSEC:0001209191-10-024890:2
- 1,900 shares@ US$4.80Common StockSEC:0001209191-10-024890:3
- 100 shares@ US$4.80Common StockSEC:0001209191-10-024890:4
- 120,000 shares@ US$0.20Common StockSEC:0001209191-09-043607:0
- 7,403 shares@ US$0.19Common StockSEC:0001209191-09-042966:0
- 1,050 shares@ US$0.19Common StockSEC:0001209191-09-042966:1
- 150,000 shares@ US$4.56Common StockSEC:0001209191-09-043133:0
- 34,920 shares@ US$0.21Common StockSEC:0001209191-09-041818:0
- 1,000 shares@ US$0.19Common StockSEC:0001209191-09-041818:1
- 22,100 shares@ US$0.20Common StockSEC:0001209191-09-041466:0
- 7,900 shares@ US$0.20Common StockSEC:0001209191-09-041466:1
- 5,080 shares@ US$0.19Common StockSEC:0001209191-09-041466:2
- 300,000 shares@ US$0.19Common StockSEC:0001209191-09-034677:0
- 60,000 shares@ US$0.17Common StockSEC:0001209191-08-062004:0Canonical exit: 17 Feb 2009 (T+90)
- 100 shares@ US$2.44Common StockSEC:0001209191-08-036392:0Canonical exit: 8 Sept 2008 (T+90)
- 200 shares@ US$2.33Common StockSEC:0001209191-08-036392:1Canonical exit: 8 Sept 2008 (T+90)
- 400 shares@ US$2.43Common StockSEC:0001209191-08-036392:2Canonical exit: 8 Sept 2008 (T+90)
- 5,000 shares@ US$2.42Common StockSEC:0001209191-08-036392:3Canonical exit: 8 Sept 2008 (T+90)
- 4,500 shares@ US$2.47Common StockSEC:0001209191-08-036392:4Canonical exit: 8 Sept 2008 (T+90)
- 13,500 shares@ US$0.29Common StockSEC:0001209191-08-032427:0Canonical exit: 18 Aug 2008 (T+90)
- 26,000 shares@ US$0.30Common StockSEC:0001209191-08-032427:1Canonical exit: 18 Aug 2008 (T+90)
25 of 31 declarations
